Start website main content

COMPOUNDS FOR INHIBITING THE INTERACTION OF SARS-COV2 WITH HUMAN PROTEIN ACE2

Back to PATENTS
  • Filing date:
  • Status: disponibile a cessione o licenza
  • Patent type: Brevetti
  • Priority Number: Composti per inibire l'interazione di SARS Cov2 con la proteina ACE2 umana
  • Technologic Area: Farmaceutica
  • Espacenet https://worldwide.espacenet.com/publicationDetail…
  • Assignees: Scuola Superiore Sant'Anna, Istituto Italiano Tecnologia, Università di Milano
  • Inventors: Paolo Ciana, Brunialti Electra, Villa Alessandro Maria Giovanni, Angelo Reggiani, Vincenzo Lionetti

The invention concerns the use of DNA aptamers that can shield the SARS-CoV-2 binding site on the cell, and halt the cell-to-cell spreading of coronavirus. The novel oligonucleotide, and the anti-coronavirus strategy based on the protection of the target cell, are innovative technologies that could be developed into a novel COVID-19 therapy that is effective against variants of the virus....more